Principal Financial Group (PFG) shares trade at $112.67, barely moved by a third-quarter report that UBS described as a headline miss. The weekly uptrend is intact, and the balance of evidence for the next two to six weeks leans positive, with medium conviction. The stock sits just above its 50-day average at $112.21. From a breakout the math reaches only 0.7 to 1, well short of the 3 to 1 that makes a breakout worth the risk.
Why it matters
PFG filed its quarterly report on SEC EDGAR on October 29, 2026. It showed revenue of $4.62 billion, up 25% from a year earlier, net income of $631.9 million, and diluted earnings per share of $2.91. Those growth rates look strong on their face. Analysts still treated the quarter as a shortfall against expectations, and that is what moved estimates.
The market's response was mild. The stock's recent closing peak was $113.65 on October 29, the day of the filing, and it is now 0.9% below that. It is up 0.5% over the past month. A stock that barely flinches at a miss is telling you the disappointment was either expected or not large enough to change how holders see the business.
Over five days the stock gained 0.5%, while the S&P 500 fell 2.1% and the financial sector ETF (XLF) rose 2.3%. PFG held up against a falling market but lagged its own sector by about 1.8 points. Over 50 days the picture is the same: ahead of the S&P 500 by 2.2%, behind XLF by 1.8%. Nothing in the news explains why financials rallied while the broad market slipped, so that divergence is unexplained. The other earnings headlines this week concern other companies and say nothing about PFG.
The argument about PFG is a debate over earnings power and what it is worth. On the cautious side, Investing.com reports that UBS cut its price target to $112 from $120 and kept a Neutral rating. It lowered its 2026 earnings estimate to $9.10 from $9.32 and its 2027 estimate to $9.63 from $9.86, citing the quarter's miss and multiple compression across asset managers. Wells Fargo also cut its target on October 20, 2026, though no figure is available. The feed holds no equivalent bullish note. The constructive case rests on the filing's growth figures and on a chart that has absorbed the news without breaking.
Valuation leaves little room. Twelve analysts rate the stock a consensus hold, with a mean target of about $109.42, so the price is 3.0% above it. Targets run from $86 to $125. The stock trades above UBS's $112 and well above the mean, so the market is already paying for more than the typical analyst models.
What the evidence says
The long-term thesis is intact. The stock is above its 40-week average and its 200-day average at $103.80, and it is up 27.6% this year and 11.3% over six months. It sits 4.9% below its 52-week high of $118.51 and far above the $81.01 low. The phase is a pullback and consolidation inside an uptrend, not a topping pattern. The RSI at 65.7 shows strong momentum without being stretched.
For the next two to six weeks the balance of evidence leans positive, with medium conviction: two of four checks support it. The daily trend runs with the weekly uptrend, and the stock is leading the S&P 500 over 50 days. The third check fails, because it lags XLF over 50 days, against the trend. That lag, together with the limits below, is why conviction is not higher.
The strongest case against this reading is that the earnings story is deteriorating while the price holds up. UBS and Wells Fargo have both cut targets, the stock trades above the consensus target, and volume is running 58.6% below its 20-day average, so the recent stability has little buying behind it. The case does not tip the balance because the price has not broken any level that matters, and the muted reaction to a miss suggests sellers are not in a hurry. It does cap the conviction.
Levels that matter
The structure holds above $112.21, the 50-day average, and the stock sits just above it now. A close below would be the first crack. The trend ends below $111.01, a swing zone, because that is where earlier buyers stepped in. Below that, the next supports are $105.50 and the 200-day average at $103.80.
The breakout level is a daily close above $115.77, a swing zone, on volume above its 20-day average. Volume is the part not yet in evidence. The first target is the 52-week high at $118.51. A breakout would be wrong below $111.57, which is the 50-day average minus a quarter of the 14-day average true range. That gives 0.7 to 1 in reward to risk, so the math does not reach 3 to 1. It would take a path beyond the 52-week high, with $125 the next marked level, to change that arithmetic.
What would change the picture
A weekly close below $111.01 would change the picture, because it would end the trend and turn a pullback into a break. The non-price fact most likely to do it is further evidence that the third-quarter shortfall is recurring rather than one-off, such as another round of estimate cuts that pushes 2026 earnings below the $9.10 UBS now models.
What to watch
- Earnings: the date in the data, October 26, 2026, has already passed and the third-quarter results are out. No later date is listed. The number that matters is full-year 2026 earnings per share against UBS's $9.10.
- Sector: XLF rose 2.3% over five days and 6.9% over a month. If that rally fades, PFG's lag matters less. If it continues, PFG's lag becomes the story.
- Volume: a breakout needs volume above its 20-day average, and it is currently well below.
- Valuation: the stock is 3.0% above a mean target of about $109.42, with a range of $86 to $125.